- Home
- RDY vs BFH Comparison
RDY vs BFH Comparison
Compare RDY & BFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- BFH
- Stock Information
- Founded
- RDY 1984
- BFH 1996
- Country
- RDY India
- BFH United States
- Employees
- RDY N/A
- BFH N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- BFH Business Services
- Sector
- RDY Health Care
- BFH Consumer Discretionary
- Exchange
- RDY Nasdaq
- BFH Nasdaq
- Market Cap
- RDY 2.1B
- BFH 2.5B
- IPO Year
- RDY N/A
- BFH N/A
- Fundamental
- Price
- RDY $13.45
- BFH $49.90
- Analyst Decision
- RDY Buy
- BFH Hold
- Analyst Count
- RDY 1
- BFH 15
- Target Price
- RDY $17.00
- BFH $61.50
- AVG Volume (30 Days)
- RDY 2.2M
- BFH 1.0M
- Earning Date
- RDY 05-16-2025
- BFH 04-24-2025
- Dividend Yield
- RDY 0.73%
- BFH 1.66%
- EPS Growth
- RDY 2.68
- BFH N/A
- EPS
- RDY 0.75
- BFH 5.57
- Revenue
- RDY $3,637,607,642.00
- BFH $2,445,000,000.00
- Revenue This Year
- RDY $17.74
- BFH $61.94
- Revenue Next Year
- RDY $9.32
- BFH $5.29
- P/E Ratio
- RDY $17.82
- BFH $9.07
- Revenue Growth
- RDY 14.74
- BFH N/A
- 52 Week Low
- RDY $12.26
- BFH $38.21
- 52 Week High
- RDY $16.89
- BFH $66.71
- Technical
- Relative Strength Index (RSI)
- RDY 52.27
- BFH 58.48
- Support Level
- RDY $13.17
- BFH $47.87
- Resistance Level
- RDY $14.06
- BFH $51.44
- Average True Range (ATR)
- RDY 0.20
- BFH 1.71
- MACD
- RDY -0.05
- BFH 0.48
- Stochastic Oscillator
- RDY 54.44
- BFH 80.58
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About BFH Bread Financial Holdings Inc.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business that partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.